Onconetix, Inc. (ONCO)
ONCO Stock Price Chart
Explore Onconetix, Inc. interactive price chart. Choose custom timeframes to analyze ONCO price movements and trends.
ONCO Company Profile
Discover essential business fundamentals and corporate details for Onconetix, Inc. (ONCO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Feb 2022
Employees
12.00
Website
https://onconetix.gcs-web.comCEO
David Allan White
Description
Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The company's product lineup includes Entadfi, an FDA-cleared, once-daily oral medication. This prescription drug combines finasteride and tadalafil to manage benign prostatic hyperplasia (BPH). In its development pipeline, Onconetix is advancing a Streptococcus pneumoniae vaccine candidate, designed to prevent infectious middle ear infections in children and pneumonia in the elderly. Additionally, they are working on a universal influenza vaccine intended to provide comprehensive protection against all aggressive strains of the flu virus. Furthermore, Onconetix holds a license for an advanced norovirus S&P nanoparticle virus-like particle (VLP) vaccine platform from Cincinnati Children's. This adaptable platform is being leveraged to create vaccines for various infectious diseases, such as Marburg and monkeypox, among others. Established in 2018, the company was previously known as Blue Water Biotech, Inc., before changing its name to Onconetix, Inc. in December 2023. Its corporate headquarters are located in Cincinnati, Ohio.
ONCO Financial Timeline
Browse a chronological timeline of Onconetix, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
EPS estimate is -$4.51k, while revenue estimate is $21.88k.
Stock split effective on 21 May 2026
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2026
EPS came in at -$6.71 , while revenue for the quarter reached $21.46k .
Stock split effective on 25 Mar 2026
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Mar 2026
EPS came in at $12.58 , while revenue for the quarter reached $303.60k .
Earnings released on 13 Nov 2025
EPS came in at -$31.25 , while revenue for the quarter reached $303.65k .
Earnings released on 14 Aug 2025
EPS came in at -$20.25 , while revenue for the quarter reached $106.49k .
Stock split effective on 13 Jun 2025
Shares were split 1 : 85 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Jun 2025
EPS came in at $1.06 , while revenue for the quarter reached $101.63k .
Earnings released on 2 Jun 2025
EPS came in at -$6.40 , while revenue for the quarter reached $711.98k .
Earnings released on 9 Dec 2024
EPS came in at -$9.49 , while revenue for the quarter reached $406.86k .
Stock split effective on 24 Sept 2024
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Aug 2024
EPS came in at -$0.23 , while revenue for the quarter reached $704.85k .
Earnings released on 20 May 2024
EPS came in at -$0.16 , while revenue for the quarter reached $700.43k , beating expectations by +1.11k%.
Earnings released on 11 Apr 2024
EPS came in at -$0.29 surpassing the estimated -$3.57k by +99.99%, while revenue for the quarter reached $58.47k , beating expectations by +0.80%.
Earnings released on 17 Nov 2023
EPS came in at -$0.27 surpassing the estimated -$3.23k by +99.99%.
Earnings released on 20 Oct 2023
EPS came in at -$3.06k falling short of the estimated -$2.04k by -50.00%.
Earnings released on 12 May 2023
EPS came in at -$3.06k surpassing the estimated -$3.49k by +12.20%.
Earnings released on 9 Mar 2023
EPS came in at -$3.40k surpassing the estimated -$4.51k by +24.53%.
Earnings released on 10 Nov 2022
EPS came in at -$4.59k .
Earnings released on 30 Jun 2022
EPS came in at -$1.21k .
Earnings released on 31 Mar 2022
EPS came in at -$1.11k .
Earnings released on 31 Dec 2021
EPS came in at -$370.38 .
Earnings released on 30 Sept 2021
EPS came in at -$337.31 .
ONCO Stock Performance
Access detailed ONCO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
